Neville Rodie & Shaw Inc. Sells 2,440 Shares of Intuitive Surgical, Inc. $ISRG

Neville Rodie & Shaw Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 7,987 shares of the medical equipment provider’s stock after selling 2,440 shares during the period. Neville Rodie & Shaw Inc.’s holdings in Intuitive Surgical were worth $3,572,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Aaron Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after acquiring an additional 19 shares during the period. Evergreen Capital Management LLC boosted its stake in Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after purchasing an additional 20 shares during the period. Rise Advisors LLC boosted its stake in Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares during the period. Pinnacle Bancorp Inc. increased its holdings in Intuitive Surgical by 4.1% during the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 21 shares in the last quarter. Finally, Vertex Planning Partners LLC raised its stake in shares of Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.9%

ISRG stock opened at $542.32 on Monday. The company has a market cap of $194.41 billion, a price-to-earnings ratio of 71.74, a P/E/G ratio of 4.98 and a beta of 1.68. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The business has a 50 day moving average price of $529.62 and a two-hundred day moving average price of $505.36.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the firm posted $1.84 EPS. The firm’s revenue for the quarter was up 22.9% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. The Goldman Sachs Group raised their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $608.79.

Insider Activity

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This trade represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 22,806 shares of the business’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the transaction, the insider owned 2,694 shares in the company, valued at $1,537,977.66. This represents a 89.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 109,043 shares of company stock valued at $60,816,225. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.